Moderna Quarterly Earnings Release Scheduled for February 14, 2025
Moderna is set to release its quarterly earnings on February 14, 2025. The earnings report is expected to show a decline in revenue and earnings per share (EPS) compared to the previous quarter.
Key Metrics to Watch
- Analysts predict a significant decline in revenue
- EPS is expected to be lower than the previous quarter
- The company’s stock has declined 65% over the past year
Factors Contributing to Decline
- Waning vaccine demand
- Uncertainty surrounding Moderna’s pipeline
- Market fatigue
- Limited cash reserves
Potential Takeover Speculation
There is speculation about a potential takeover, which could offer shareholders an exit from the turmoil. However, analysts remain bearish on Moderna due to market fatigue, limited cash reserves, and a prolonged timeline to become profitable again.
Projected Earnings
The upcoming earnings report is expected to reveal a stark reversal in the company’s fortunes, with revenues projected to fall sharply and EPS expected to be negative.